PO.7.156 Does expert opinion match the definitions of low disease activity state? Prospective analysis of 500 patients from a spanish multicenter cohort

Autor: I Rua-Figueroa, N Jimenez, M Galindo, C Mouriño, JM Pego-Reigosa, TC Salman-Monte, I Altabás González, F Rubiño, R Menor Almagro, E Uriarte Isacelaya, E Tomer Muriel, I Carrión-Barberà, E Rodríguez-Almaraz

Publikováno v: Lupus Science and Medicine, Vol 9, Iss Suppl 2 (2022)

Externí odkaz: https://doaj.org/article/3528180e49784a21a2f1cd9ebbb6ac96

Prevalence and risk factors for serositis in patients with systemic lupus erythematosus: A case-control study.

Autor: Gimeno-Torres, Laura^1,2 (AUTHOR), Carrión-Barberà, Irene² (AUTHOR) ipirenaica@gmail.com, Durán, Xavier³ (AUTHOR), Villegas, Eduardo⁴ (AUTHOR), Monfort, Jordi² (AUTHOR), Salman-Monte, Tarek Carlos² (AUTHOR)

Publikováno v: Lupus. Nov2021, Vol. 30 Issue 13, p2095-2101. 7p. 3 Charts, 1 Graph.

Differences between clinical and laboratory findings in patients with recent diagnosis of SLE according to the positivity of anti-dsDNA by the Crithidia luciliae method.

Autor: Sarbu, M. I.¹, Salman-Monte, T. C.¹ tareto4@gmail.com, Rubio Muñoz, P.¹, Lisbona, M. P.¹, Bernabé, M. Almirall¹, Carbonell, J.¹

Publikováno v: Lupus. Oct2015, Vol. 24 Issue 11, p1198-1203. 6p. 1 Chart.

Contributions of the lupus register of the Spanish Society of Rheumatology (RELESSER) to the knowledge of systemic lupus erythematosus in Spain.

Autor: Rúa-Figueroa Fernández de Larrinoa I; Servicio de Reumatología, Hospital Universitario de Gran Canaria Doctor Negrín, Gran Canaria, España. Electronic address: iruafer@gobiernodecanarias.org., Pego-Reigosa JM; Servicio de Reumatología, Complejo Hospitalario Universitario de Vigo, Vigo, España.

Publikováno v: Reumatologia clinica [Reumatol Clin (Engl Ed)] 2021 May; Vol. 17 (5), pp. 245-249. Date of Electronic Publication: 2020 Mar 21.

Influence of anti-osteoporosis treatments on the incidence of COVID-19 in patients with non-inflammatory rheumatic conditions.

Autor: Blanch-Rubió J; Rheumatology Service, Hospital del Mar, Passeig Marítim, Barcelona 08003 , Spain.; IMIM (Hospital del Mar Medical Research Institute), PRBB, Barcelona 08003, Spain., Soldevila-Domenech N; Integrative Pharmacology and Systems Neuroscience Research Group, Neurosciences Research Program, IMIM-Institut Hospital del Mar d’Investigacions Mèdiques, PRBB, Barcelona 08003, Spain.; Department of Experimental and Health Sciences, Universitat Pompeu Fabra, PRBB, Barcelona 08003, Spain., Tío L; IMIM (Hospital del Mar Medical Research Institute), PRBB, Barcelona 08003, Spain., Llorente-Onaindia J; IMIM (Hospital del Mar Medical Research Institute), PRBB, Barcelona 08003, Spain., Ciria-Recasens M; Rheumatology Service, Hospital del Mar, Passeig Marítim, Barcelona 08003 , Spain.; IMIM (Hospital del Mar Medical Research Institute), PRBB, Barcelona 08003, Spain., Polino L; IMIM (Hospital del Mar Medical Research Institute), PRBB, Barcelona 08003, Spain., Gurt A; CAP Vila Olímpica, Parc Sanitari Pere Virgili, Barcelona 08005, Spain., de la Torre R; Integrative Pharmacology and Systems Neuroscience Research Group, Neurosciences Research Program, IMIM-Institut Hospital del Mar d’Investigacions Mèdiques, PRBB, Barcelona 08003, Spain.; Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition (CIBERObn), Instituto de Salud Carlos III (ISCIII), Madrid 28029, Spain.; Department of Experimental and Health Sciences, Universitat Pompeu Fabra, PRBB, Barcelona 08003, Spain., Maldonado R; IMIM (Hospital del Mar Medical Research Institute), PRBB, Barcelona 08003, Spain.; Laboratory of Neuropharmacology, Department of Experimental and Health Sciences, Universitat Pompeu Fabra, PRBB, Barcelona 08003, Spain., Monfort J; Rheumatology Service, Hospital del Mar, Passeig Marítim, Barcelona 08003 , Spain.; IMIM (Hospital del Mar Medical Research Institute), PRBB, Barcelona 08003, Spain.

Publikováno v: Aging [Aging (Albany NY)] 2020 Oct 20; Vol. 12 (20), pp. 19923-19937. Date of Electronic Publication: 2020 Oct 20.